One number that may bring foreign investors back into the Indian stock market

FIIs are looking beyond the price-to-earnings ratio.

FIIs are looking beyond the price-to-earnings ratio.

Mukesh Jindal, Senior Partner at Alpha Capital, shares his views on cryptocurrencies, Bitcoin’s growth, investment strategies, risks with altcoins, and why investors should limit crypto exposure to 5%.

The NSE Nifty 50 rose 104 points, or 0.42%, to 24,981, while the S&P BSE Sensex gained 371 points, or 0.46%, to 81,644. The Nifty Bank index added 130 points to 55,865.

The project, awarded on a Bill of Quantities (BOQ) basis, carries a completion timeline of 24 months. The scope of work involves full execution of the stadium project. Shares of Globe Civil Projects Ltd ended at ₹78.73, up by ₹0.26,…

Russian crude sourcing continues to support margins, with discounts in the range of $2-3 per barrel. BPCL expects 35% of its crude requirement this fiscal to come from Russia, while HPCL’s share stood at 13%.

Ventura attributed the outlook to macroeconomic headwinds, geopolitical risks, and sustained investment demand.

Pharma stocks has outperformed the MSCI India Index by 40% in the last three years. However, several looming challenges threaten the momentum in many of the stocks. Scroll down for three names that the analysts continue to be bullish on.

Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension in adults to reduce the risks of disease progression and hospitalisation, the company said.

Earlier this month, Sarda Energy said it is considering scaling its upcoming power project from the previously planned 600 MW to 800 MW.

In the crucial Q1 results, the company reported a 20.1% year-on-year decline in consolidated net profit for the June quarter at ₹8,734 crore. This was lower than the ₹10,934 crore a year ago. However, the numbers surpassed the CNBC-TV18 estimates,…